NCT06943664 2026-03-24Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerRoswell Park Cancer InstitutePhase 2 Not yet recruiting27 enrolled
NCT04836429 2026-02-04Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural DiseaseRoswell Park Cancer InstitutePhase 1 Terminated5 enrolled